PFE vs WMT: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Walmart Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
VS
Walmart Inc. ยท Consumer Defensive
$106.73
-10.8% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
PFE has more upside to fair value (+12.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric PFE WMT
Current Price $27.64 $106.73
Fair Value Estimate $30.94 $95.24
Upside to Fair Value +12.0% -10.8%
Market Cap $157.5B $849.4B
Forward P/E โ€” โ€”
EV / EBITDA 17.4x 21.3x
Price / Sales 2.5x 1.1x
Price / FCF 14.3x 62.8x
Revenue Growth YoY +2.6% +5.9%
Gross Margin 71.3% 25.2%
Operating Margin 25.1% 4.4%
Return on Equity 4.9% 22.7%
Dividend Yield 6.22% 0.92%
FCF Yield 6.97% 1.59%
Analyst Consensus Hold Strong Buy
Investment Thesis
PFE โ€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โ€ฆ
WMT โ€” Walmart Inc.
Walmart Inc. is the world's largest retailer by revenue, operating more than 10,000 stores and clubs across Walmart U.S., Walmart International, and Sam's Club, with a fast-growing e-commerce and advertising ecosystem layered on top of a grocery-led, everyday-low-price model. The business quality is high: scale and sourcing power underpin a durable cost advantage, ROE is 22.7%, and revenue grew 5โ€ฆ
Accumulation Zones
Metric PFE WMT
Zone Low $23.21 $71.43
Zone High $26.30 $80.95
In Buy Zone? No No
โ† PFE Research    WMT Research โ†’    All Research